BioNeutra Global Corporation
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more
BioNeutra Global Corporation (BGACF) - Total Liabilities
Latest total liabilities as of September 2024: $21.81 Million USD
Based on the latest financial reports, BioNeutra Global Corporation (BGACF) has total liabilities worth $21.81 Million USD as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BioNeutra Global Corporation - Total Liabilities Trend (1997–2023)
This chart illustrates how BioNeutra Global Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BioNeutra Global Corporation Competitors by Total Liabilities
The table below lists competitors of BioNeutra Global Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ANGLO AMERICAN - Dusseldorf Stock Exchang
DU:NGLB
|
Germany | €34.93 Billion |
|
Cann-Is Capital Corp
V:NIS-P
|
Canada | CA$142.73K |
|
H&R.BLOCK (HRB.SG)
STU:HRB
|
Germany | €2.92 Billion |
|
Regent Pacific Properties Inc
V:RPP
|
Canada | CA$20.12 Million |
|
ChemX Materials Ltd
AU:CMX
|
Australia | AU$3.91 Million |
|
General Shopping e Outlets do Brasil S.A.
SA:GSHP3
|
Brazil | R$2.45 Billion |
|
Vivid Seats Inc. Warrant
NASDAQ:SEATW
|
USA | $771.58 Million |
Liability Composition Analysis (1997–2023)
This chart breaks down BioNeutra Global Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BioNeutra Global Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BioNeutra Global Corporation (1997–2023)
The table below shows the annual total liabilities of BioNeutra Global Corporation from 1997 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $21.96 Million | -6.70% |
| 2022-12-31 | $23.54 Million | +6.42% |
| 2021-12-31 | $22.12 Million | -3.74% |
| 2020-12-31 | $22.98 Million | -21.51% |
| 2019-12-31 | $29.27 Million | +33.49% |
| 2018-12-31 | $21.93 Million | +28.88% |
| 2017-12-31 | $17.01 Million | -18.26% |
| 2016-12-31 | $20.81 Million | +79.56% |
| 2015-12-31 | $11.59 Million | +263.80% |
| 2014-12-31 | $3.19 Million | -25.00% |
| 2013-12-31 | $4.25 Million | +24746.52% |
| 2012-12-31 | $17.10K | -86.93% |
| 2011-12-31 | $130.79K | +196.13% |
| 2010-12-31 | $44.17K | -74.49% |
| 2009-12-31 | $173.16K | -86.81% |
| 2008-12-31 | $1.31 Million | +18.51% |
| 2007-12-31 | $1.11 Million | -51.51% |
| 2006-12-31 | $2.28 Million | -55.99% |
| 2005-12-31 | $5.19 Million | +9.77% |
| 2004-12-31 | $4.73 Million | +123.53% |
| 2003-12-31 | $2.12 Million | -33.96% |
| 2002-12-31 | $3.20 Million | +52.94% |
| 2001-12-31 | $2.09 Million | +60.44% |
| 2000-12-31 | $1.31 Million | -23.21% |
| 1999-12-31 | $1.70 Million | +325.00% |
| 1998-12-31 | $400.00K | +100.00% |
| 1997-12-31 | $200.00K | -- |